Chargement en cours...
Tetrabenazine in treatment of hyperkinetic movement disorders: an observational study
BACKGROUND: Tetrabenazine (TBZ) is commonly used in hyperkinetic movement disorders. In this retrospective study, we aimed to assess the TBZ effectiveness and adverse events (AEs) in Huntington disease (HD), vascular chorea, tics, dystonia, tardive oromandibular (OM) dyskinesia and other tardive syn...
Enregistré dans:
| Publié dans: | Ther Adv Neurol Disord |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5367646/ https://ncbi.nlm.nih.gov/pubmed/28382107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285616677004 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|